Aelis Farma Announces its 2023 Financial Calendar

BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS, PEA-PME eligible) (Paris: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases, today announces its indicative financial calendar for the financial year 2023. Event Date of release* 2022 Annual Results Monday, April 3, 2023 Annual General Meeting Wednesday, May 24, 2023 2023 Half-Year Results Monday, September 25, 2023 (*) The press releases will be issued after the close of trading. Information may be subject to change. About AELIS FARMA Founded in 2013, Aelis Farma is a biopharmaceutical company that is developing a new class of drugs, the Signaling Specific inhibitors of the CB1 receptor of the endocannabinoid system (CB1-SSi). These new molecular entities hold great potential in the treatment of many brain diseases. CB1-SSi were developed by Aelis Farma on the basis of the discovery of a new natural defense mechanism of the brain made by the team of Dr. Pier Vincenzo Piazza, CEO of the Company, when he was Director of the Magendie Neurocenter of Inserm in Bordeaux. By reproducing this natural mechanism, CB1-SSi appear to be able to selectively inhibit the disease-related activity of the CB1 receptor, without disrupting its normal physiological activity. For these discoveries, Dr. Piazza was awarded the Inserm Grand Prix and the Grand Prix of Neurology of the French Academy of Sciences, which are among the most prestigious French awards in medicine and neurology. Aelis Farma is developing two first-in-class drug candidates that are at the clinical stage, AEF0117 and AEF0217, and has a portfolio of innovative CB1-SSi for the treatment of other diseases associated with a dysregulation of the activity of the CB1 receptor. AEF0117, which targets disorders due to excessive cannabis use (addiction and psychosis), has shown indications of efficacy in a phase 2a clinical trial and has entered a phase 2b clinical trial in Q2 2022, which will include 330 patients in 12 clinical centers in the United States. Aelis Farma has an exclusive option-license agreement with Indivior PLC, a leading pharmaceutical company in the treatment of addiction, for the development and commercialization of AEF0117 for disorders due to excessive cannabis use. As part of this agreement, Aelis Farma has already received $30 million (option payment). If Indivior exercises the license option at the end of the phase 2b, Aelis Farma will receive a $100 million license fee (potentially in 2024) and Indivior will carry any additional development costs. The agreement also includes up to $340 million in additional payments contingent on the achievement of development, regulatory and commercial milestones, as well as royalties on net sales of AEF0117 ranging between 12% and 20%. AEF0217, which targets various cognitive disorders including those associated with Down syndrome (trisomy 21), has successfully completed safety and pharmacokinetic trials (phase
http://dlvr.it/ShkwWC

Virpax Pharmaceuticals Engages New England Investors to Direct Licensing Strategy for Envelta™ in China

BERWYN, Pa.--(BUSINESS WIRE)--Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, and central nervous system (CNS) disorders, today announced that the Company has engaged New England Investors, LLC to serve as the out-licensing advisor for Envelta in the People’s Republic of China. Envelta is Virpax’s non-opioid pain product candidate for acute and chronic pain including non-cancer pain. “
http://dlvr.it/ShkVCc

Gibraltar to Record Fourth Quarter 2022 Charge for Processing Business Write-Down

BUFFALO, N.Y.--(BUSINESS WIRE)--Gibraltar Industries, Inc. (Nasdaq: ROCK), a leading manufacturer and provider of products and services for the renewable energy, residential, agtech and infrastructure markets, today announced it will record a fourth quarter 2022 non-cash charge estimated to be $14 million, or $0.35 per share, to write down assets associated with its processing equipment business, which was classified as held for sale as of March 31, 2022, to estimated fair market value. As a result, the Company now expects GAAP earnings per share for the year ended December 31, 2022 to be in the range of $2.50 to $2.60, down from the prior estimated range of $2.90 to $3.00. The revenue range of $1.38 billion to $1.43 billion and adjusted EPS range of $3.30 to $3.40 for the year ended December 31, 2022 are unaffected by the write-down. Chairman and CEO Bill Bosway stated, “The depressed dynamics of the cannabis and hemp processing equipment market led us to pursue a divestiture of these assets. As we continue our efforts to sell this business, we have determined that its estimated fair market value is less than its carrying amount, and therefore will be taking a charge to adjust book value to estimated market value. We continue to focus on our core Agtech greenhouse solutions that support our growers in the produce, commercial and cannabis markets.” Gibraltar has provided an estimate of the non-cash charge and a range of expected GAAP earnings because the closing procedures for the fiscal quarter and year ended December 31, 2022 are not yet complete. The preliminary financial information presented in this press release reflects current expectations based solely on information available as of the date of this press release and is subject to change, and may be adjusted as a result of, among other things, the completion of the Company’s financial and operating closing procedures, customary audit procedures, and other developments that may occur before the completion of these procedures. Accordingly, you should not place undue reliance on these preliminary financial results, which may differ materially from actual results. See “Forward-Looking Statements” below for a discussion of certain factors that could result in differences between the preliminary estimated unaudited consolidated financial results reported in this press release and actual results. Fourth Quarter 2022 Conference Call Details Gibraltar plans to release its fourth quarter 2022 financial results at approximately 7:30 a.m. ET on Wednesday, February 22, 2023, and will host a conference call that will be webcast live that same day starting at 9:00 a.m. ET. Those who wish to listen to the conference call should visit the Investors section of the Company’s website at www.gibraltar1.com. The call also may be accessed by dialing (877) 407-3088 or (201) 389-0927. For interested individuals unable to join the live conference call, a webcast replay will be available on the Company’s website for one year. About Gibraltar Gibraltar is a leading manufacturer and provider of products and services for the renewable energy, residential, agtech,
http://dlvr.it/Shk0Wc

Global Pet Clothing Market Report 2022 to 2028: Increasing Demand For Recycled Fabrics For Pet Clothes Drives Growth – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Pet Clothing Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Product Type, By Pet Owner (Millennial, Gen X, Baby Boomer, Gen Z), By Pet Type (Dogs, Cats), By Regional Outlook and Forecast, 2022 - 2028" report has been added to ResearchAndMarkets.com's offering. The Global Pet Clothing Market size is expected to reach $6.3 billion by 2028, rising at a market growth of 4.0% CAGR during the forecast period. Pet clothes are specifically created apparel for companion animals. These clothes are usually made to serve a function like protecting pets against pests or keeping them warm and dry. Silk, cotton, quilted canvas, and wool are some of the common fabrics that are used to make these clothes. Pet clothing includes apparel that provides additional warmth and shields dogs from the extremes. Some typical examples of pet clothing are jackets, sweaters, knitwear, hoodies, shirts, head and neckwear, raincoats, and swimwear. Most of the pet clothing available is designed for little dogs. Small dogs naturally have very thin coats and are prone to catch cold in cooler or wetter conditions. The warmth from pet clothing, such as a raincoat, jacket, or sweater, might prevent the dogs from shivering when out for a stroll. With the fame these clothes got, they are now also available for larger dogs and cats. Nowadays, pet owners enjoy dressing up their animals with clothes to make them stand out from other animals and look fashionable. This practice also helps pet owners improve their social standing in society. While certain outfits, like a pet tuxedo or a costume, are purely whimsical and decorative, other accessories, like raincoats and sweaters, are more useful. All dog sizes can find coats and sweaters, and some knitters enjoy making dog sweaters by hand. Smaller dog breeds with short hair, like Chihuahuas and dachshunds, are especially popular for sweaters and coats. Similarly, cat owners also like to dress their pets in sweaters. To meet customer demands, manufacturers are introducing products with distinctive designs, characters, sizes, colors, and patterns. For instance, producers have debuted some of the most well-known franchises and characters, including Batman, Wonder Woman, Mickey Mouse, Jurassic World, Ghostbusters, etc. Market Growth Factors Rising Awareness Of Pets' Health Among Pet Owners As pets grow, their age and health issues also necessitate the use of clothing. Pets' immune systems deteriorate when they become ill. As a result, wearing garments can keep them healthy. Finding appropriate clothing for dogs, such as sweaters, is necessary because, for instance, hypothermia is a prevalent sickness in dogs. In addition, some animals have delicate skin, particularly after a haircut. They will face more environmental dangers as a result. Thus, clothing can shield them from the sun's rays and other dangers. Pets are also more susceptible to the cold during winter, especially the younger and the aged ones. In the winter, it might be difficult for such vulnerable pets to
http://dlvr.it/Shg7t2

POSaBIT to Acquire MJ Platform, Leaf Data Systems and Ample Organics for US$4 Million Adding 350+ Merchants and More than US$2 Billion in GMV

POSaBIT secures up to $11 million in debt and equity financing Conference Call Monday at 4:30 p.m. ET WASHINGTON: POSaBIT Systems Corporation, a leading provider of payments infrastructure in the cannabis industry, today announced it has signed a definitive agreement to acquire MJ Platform, Leaf Data Systems and Ample Organics from Akerna Corp. for US$4 Read the full article...
http://dlvr.it/ShXqw7

Global Cellulose Fibers Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunity and Forecasts – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cellulose Fibers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The global cellulose fibers market size reached US$ 27.6 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 45.6 Billion by 2027, exhibiting a CAGR of 8.73% during 2021-2027. Companies Mentioned CFF GmbH & Co. KG China Bambro Textile (Group) Co. Ltd. Daicel Corporation Eastman Chemical Company Fulida Group Holdings Co. Ltd. Grasim Industries Ltd. Kelheim Fibres Lenzing AG Sateri Holdings Ltd. Shandong Helon Textiles Sci. & Tech. Co. Ltd. Tangshan Sanyou Xingda Chemical Fiber Co. Ltd. Zhejiang Fulida Co. Ltd. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic end use industries. These insights are included in the report as a major market contributor. Cellulose fiber refers to a natural or artificial fiber that is manufactured using wood pulp. It can also be produced using esters of leaves, wood and barks of the plants and other plant-based materials. The other natural fibers are obtained from cotton, jute, flax, hemp and ramie, whereas artificial fibers majorly include lyocell, viscose and modal. These fibers are extremely light-weight and exhibit high moisture absorbency and strength, owing to which they are majorly used for manufacturing fabrics, home textiles, biocomposites, polymer composites and chemical filters. Significant growth in the textile industry across the globe is one of the key factors driving the growth of the market. Furthermore, increasing environmental consciousness has facilitated the demand for biodegradable fabrics, which is acting as another major growth-inducing factor. Cellulose fibers are primarily manufactured using wood pulp, which is skin-friendly, biodegradable and environment-friendly in nature, owing to which they are widely adopted in the textile industry. Additionally, increasing product utilization for manufacturing industrial textiles, such as curtains and upholstery, along with advancements, such as the utilization of cellulose nanofibrils (CNFs) and cellulose nanocrystals (CNCs) to enhance the mechanical properties, biocompatibility and biodegradability of cellulose fibers, is creating a positive impact on the market growth. Other factors, including the implementation of favorable government policies promoting the use of plant-based sources in place of petrochemicals, coupled with expanding industrial applications, easy availability of raw materials, and cost-effectiveness of these fibers, are projected to drive the market further. Key Market Segmentation: The publisher provides an analysis of the key trends in each sub-segment of The global cellulose fibers market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on fiber type and application. Breakup by Fiber Type: Natural Cellulose Fibers Cotton Fibers Jute Fibers Wood Fibers Others Man-made Cellulose
http://dlvr.it/ShTzPd

Innovative Cannabis Brand Escape Artists Expands Into Michigan, Debuts Pharmaceutical-Grade Topicals

KALKASKA, Mich.--(BUSINESS WIRE)--Colorado-based cannabis brand Escape Artists, a top-selling maker of infused topicals for pain relief and recovery, today announced its expansion into the Michigan market through a partnership with 42 Degrees Processing (d/b/a Fresh Coast Extracts). Escape Artists’ award-winning line of THC+CBD dermal topical creams—containing penetration-enhancing ingredients and featuring a smooth, luxurious feel—will be formulated with THC sourced from locally trusted Michigan purveyors. “With superior performance in the Colorado market, the entire 42 Degrees team is elated to offer Escape Artists’ famed products to Michigan consumers,” said 42 Degrees’ COO, Elliot Swift, which operates a 20,000-square-foot product manufacturing, licensing and distribution facility in the Traverse City micropolitan area. Escape Artists’ pharmaceutical-grade, water soluble creams are formulated with carefully selected ingredients and ultra-bioavailable cannabis extracts that enhance dermal penetration at the cellular level, providing cannabinoid-based relief in minutes. Escape Artists THC Relief Cream (2 ounces) is available in the following SKUs for recreational sale: 1:1 CBD to THC 800mg CBD / 800mg THC (with Rose and Bergamot) 300mg CBD / 300mg THC (with Lavender) 300mg CBD / 300mg THC (Unscented) 20:1 CBD to THC 800mg CBD / 40mg THC (with Lavender) 800mg CBD / 40mg THC (with Menthol) Escape Artists products continually rank in the top 10 of Colorado topical category sales by revenue according to industry analysts, Leaflink, Headset, and BDSA, and is set to be an exciting new player in Michigan’s cannabis and wellness markets. “Since Escape Artists launched in 2017 in Colorado, the brand has been committed to providing premium products to consumers that are safe and effective—establishing the company as a leading brand in the topicals category in the state,” said Alison Di Spaltro, CEO of Escape Artists. “Now we are working to bring these products to new markets and are thrilled that the first one is Michigan. We have been blown away by how welcoming this cannabis community has been, and we are eager to get our products in the hands of new customers.” Escape Artists cannabis topicals are available at select Michigan dispensaries. For more information, visit letsescape.com. Wholesalers can place orders through Leaflink.com. About Escape Artists Escape Artists specializes in cannabis-infused products for everyday wellness and self-care. Using proven methodologies from the pharmaceutical and food science sectors, Escape Artists develops game-changing cannabinoid delivery models including dermal topicals, premium infused pre-rolls, fast-acting edibles, and highly bioavailable tinctures. The Escape Artists team understands that giving back is not optional; the brand prioritizes donations of time, talent and treasure to organizations working in service of drug war prisoners and medical cannabis patients and underrepresented populations relying on cannabis plant medicine. Founded in 2017, the women-led company is one of the most widely distributed cannabis brands in Colorado and a category sales leader that is now expanding to markets across the United States. Escape To Now: letsescape.com About
http://dlvr.it/ShMlCh

Dutchie Seeks to Open Up Pennsylvania Traceability Market, Provide Choice to Cannabis Retailers

Dutchie’s lawsuit against Akerna, Pennsylvania’s traceability system provider, will increase competition and allow cannabis retailers to use the technology platforms of their choice PENNSYLVANIA:  Dutchie, The technology platform powering cannabis commerce – announced today that they filed a lawsuit against Akerna Corporation, a cannabis traceability provider, to ensure a fair playing field for technology platforms Read the full article...
http://dlvr.it/ShKLxM

Washington Social Equity Retail License Application Window Opens Mar. 1, 2023

WASHINGTON: The Liquor and Cannabis Board (LCB) will open the application window for at least 44 social equity retail cannabis licenses Mar.1, 2023. The 30-day application window closes Mar. 30, 2023 at 5:00 p.m. The LCB has held in reserve 44 retail licenses that were forfeited, cancelled, revoked or never issued that will be available Read the full article...
http://dlvr.it/Sh7m2g

2022 Heimtextil Report: Trends, Developments and Innovations in Home Textiles – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Heimtextil 2022: Trends, Developments and Innovations in Home Textiles" report from Textiles Intelligence Ltd. has been added to ResearchAndMarkets.com's offering. The 2022 edition of Heimtextil - the world's largest international trade fair for home and contract textiles - was held in a positive spirit, despite economic and political uncertainties affecting the textile industry. The fair was the first Heimtextil to be held since 2020 and it represented a return to business as usual following the cancellation of the 2021 edition of the fair in response to the COVID-19 pandemic. One highlight of the 2022 edition of the fair was the Trend Space, which was dedicated to the presentation of design trends in architecture, art, fashion and interior design for 2022/23. Another highlight was a lecture called Future Materials Library which showcased environmentally sustainable materials and innovations produced by companies which share a goal to transition from a linear economy to a circular economy. Materials and innovations in the lecture were presented in four categories, namely Harvesting Waste Streams, Regenerative Crops, Remade Fibres, and Sustainable Colour. Themes within each category were reflected in the materials presented by exhibitors at the fair. Who should buy this report? Manufacturers of fibres, textiles, clothing and chemicals Textile and clothing machinery manufacturers - spinning, weaving, knitting, sewing and import/export Textile and clothing brands and retailers like Adidas, H&M etc. Educational institutions like universities, fashion schools etc. Business consultancy firms Textile and clothing trade associations Government trade bodies Key Topics Covered: SUMMARY INTRODUCTION TRENDS IN HOME TEXTILES FOR 2022/23 Beyond Identity Deep Nature Empowered Identity Hyper Nature FUTURE MATERIALS LIBRARY Harvesting Waste Streams Agriculture Flooring Food and cosmetics Plastics Down Regenerative Crops Flax and hemp Kapok Nettles Yak fibre Remade Fibres Sustainable Colour For more information about this report visit https://www.researchandmarkets.com/r/vdrdeo About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
http://dlvr.it/Sh3rPG

Bluestar Energy Capital Adds to Global Leadership Team and Grows Global Pipeline Following Successful US$100 Million Capital Raise

SYDNEY & CHICAGO--(BUSINESS WIRE)--Bluestar Energy Capital (‘Bluestar’ or ‘the Company’) today announced the appointment of Steve Jackson as Managing Director of its Australian renewable development platform, Bluestar Energy Australia Pty Ltd. Steve has over 30 years of experience in all facets of the Australian power industry and has held executive positions with leading private and public electricity companies. Jackson will be based in Bluestar’s Sydney CBD office. Steve has held prior positions as Vice President (APAC Regional Manager) at First Solar and Head of Development at FRV Australia. “Steve has a proven track record in establishing and scaling leading platforms in the Australian energy transition,” commented Declan Flanagan, Founder & CEO of Bluestar. “I am delighted to have such an accomplished energy executive build on our business in Australia.” “Bluestar has such a high calibre team with a fantastic track record of success in developing renewable energy projects globally. I’m fortunate to hit the ground running with great resources, one permitted wind project, and other projects having commenced development with an established developer here in Australia,” commented Jackson. “I look forward to building another high performing team of Aussie industry professionals to develop more wind, solar, and storage projects. The challenge of meeting Australian decarbonization targets is considerable, creating a huge opportunity to build a globally significant platform and I look forward to helping achieve this.” Since the completion of its US$100 million initial fundraising from founder Declan Flanagan and investors S2G Ventures and Great Bay Renewables in 2022, Bluestar has been successfully scaling its global presence. The company now has offices in Chicago, Austin, Dublin, and Sydney. Its fast-growing team consists of more than 30 professionals, and its project development pipeline already exceeds 1 gigawatt (GW), including Bluestar’s first fully permitted project in Australia, which is on track to enter construction next year. “I am very pleased with the progress we have made in a short period of time. It’s a testament to the great group of professionals at Bluestar,” commented Flanagan. “But this is a long-term and patient plan. There are plenty of challenges to the global energy transition as well as undisciplined capital chasing investments, which makes Bluestar’s greenfield development-focused strategy especially important.” About Bluestar Energy Capital Bluestar Energy Capital (Bluestar) is a global renewable energy investment company focused on development platforms and project development capital. Bluestar delivers investable clean energy projects at scale through its regional development platforms, Nova Clean Energy, LLC, and Bluestar Energy Australia. Bluestar is headquartered in Chicago, Illinois with offices in Austin, Texas, Dublin, Ireland, and Sydney. Follow Bluestar on LinkedIn. Follow our platform company, Nova Clean Energy on LinkedIn.
http://dlvr.it/Sh2Wn2

OMMA Latest Licensing Reports

OKLAHOMA: The Oklahoma Medical Marijuana Authority (OMMA) has released it’s latest statistical data for the state’s legal cannabis industry.  Below are the latest licensing reports as of this month.   OMMA Dashboard The OMMA Dashboard is maintained and updated by NCS Analytics. They have created an analytical tool that actively monitors and analyzes data from multiple systems Read the full article...
http://dlvr.it/Sh2Cls

International Cannabis Brand Cookies Expands Global Footprint with its First Asia-Based Dispensary in Thailand

BANGKOK--(BUSINESS WIRE)--International cannabis brand Cookies today announced its entrance into Thailand’s cannabis marketplace with the opening of its first dispensary in the region on Saturday, Jan. 21. Located in the internationally celebrated food, music, art and culture hub of Bangkok, the launch of Cookies Thailand marks a milestone for the brand as it enters its 6th country and becomes the 58th Cookies storefront worldwide. "The fact that my first time going to Asia is to open up a Cookies store is not something I could have ever imagined and really special," said Berner, Co-Founder and CEO of Cookies. "This store is beautiful and we are grateful for our partners on the ground in Thailand who helped make this possible. Thailand is an incredibly unique place full of incredible culture and opening up a Cookies store with the support of the country of Thailand, I am grateful for. I hope Bangkok is ready for an exclusive menu of fire genetics. I can't wait to open doors on a new continent on Saturday, 1/21/23!" To honor the Southeast Asian country’s vibrant culture, the 500-square-foot dispensary will boast a beautifully curated atmosphere with Thai-inspired wall paintings featuring a blessing from Thai Buddhist monks. As the first dispensary in Asia with a credit card machine, Cookies’ iconic cultivars and products will be available for purchase, along with exclusive Cookies SF clothing and accessories, including local reserve merchandise specific to Thailand. “Cookies Thailand evolved organically as my relationship with Berner has for over 20 years,” said Josh Schmidt, Vice President of Natura and Co-Founder of California edibles brand Dee Thai. “Driven by the right intention, while honoring Thai culture and ethos, Cookies Thailand brings our friendship full circle, bonding my two loves—cannabis and Thailand.” To commemorate the grand opening, Cookies will host a ribbon cutting ceremony on Saturday, Jan. 21 at 11 a.m. with Berner and celebrity guests, followed by a meet-and-greet with Berner. The event will feature photo opportunities with a Cookies-branded Tuk Tuk in front of the store for visitors. Visitors interested in entering Cookies Thailand must be at least 20 years old with a valid Thai National ID or foreign Passport ready to present and cannot be pregnant in accordance with local laws. To attend the grand opening, please RSVP here. Cookies Thailand is located at 51 / 2 Soi Ruamrudee, Lumpinee, Pathumwan, Bangkok 10330. Learn more at cookies.co. About Cookies Cookies, founded in 2010 by Billboard-charting rapper and entrepreneur Berner and Bay Area breeder and cultivator Jai, is the most globally recognized cannabis company in the world. Cookies values the power of the plant and focuses on creating game-changing genetics. The company offers a collection of over 70 proprietary cannabis cultivars and more than 2,000 products. Cookies also actively works to enrich communities disproportionately impacted by the War on Drugs through advocacy and social equity initiatives. Headquartered in San Francisco, the company opened its first retail store in 2018 in Los
http://dlvr.it/Sh2Cfs

FOLLOWING THE COUNCIL OF STATE’S RULING, ONE OF CBD.FR’S CUSTOMERS WILL WIN THEIR OWN WEIGHT IN CBD FLOWERS

PARIS--(BUSINESS WIRE)--On December 29, 2022, the Council of State announced the definitive authorization of the sale of CBD flowers in France. To celebrate the end of a protracted battle, CBD.fr will be offering one of its customers buying a product from its website, CBD.fr, between January 17 and April 20, 2023, the chance to win their own weight in CBD flowers. Following the purchase of CBD.fr in October 2022 by Phytocann Group and the reversal of the ban, CBD.fr can now devote itself fully to developing on national territory. Current leader in online CBD sales, with more than 500 products available, CBD.fr brings together the most well-known brands in France in varied areas such as: CBD oils, CBD flowers, CBD resins, CBD for animals, and more. At the same time, CBD.fr is developing its franchise network with the goal of opening 400 shops across France by 2026. Since January 1, 18 CBD Shops have already started opening. "This decision by the Council of State does a great deal to reassure our entire industry. It marks a huge step forward and, to celebrate this, we are organizing the hottest competition ever held in the cannabis world. Purchases made from January 1 onward will be eligible. In addition to the contest, we also want to raise awareness and contribute, in our own way, to the purchasing power of French people in our sector by offering high-quality products that are affordable for all. There is also a social aspect that we are all concerned about." Alexandre Lacarré, Founder of Phytocann Group April 20, 2023, the day on which the winner will be announced, is not just a random date. Find out who has won at 4.20 pm on 420 Day, or International Cannabis Day!
http://dlvr.it/Sh0std

BioHarvest Sciences CEO Ilan Sobel: Pioneering Plant Cell Biology for Cannabis.

By David Rheins David Rheins: Welcome to another edition of Marijuana Channel One. It is my pleasure this morning to talk to the CEO of BioHarvest Sciences, Ilan Sobel.  Thank you for joining us today. Ilan Sobel: David, it is an absolute pleasure to be on your network and on your show. DR: So you Read the full article...
http://dlvr.it/SgzJnM

Addiction Disorders Drugs Market Report 2022: Increasing Prevalence of Addictive Substances Such as Alcohol, Tobacco, and Drugs Among All Age Groups Drives Growth – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Addiction Disorders Drugs Market Research Report by Drug Type, Treatment, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering. The Global Addiction Disorders Drugs Market size was estimated at USD 22.55 billion in 2021, USD 23.95 billion in 2022, and is projected to grow at a CAGR of 6.35% to reach USD 32.65 billion by 2027. Market Statistics: The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period. Market Segmentation & Coverage: This research report categorizes the Addiction Disorders Drugs to forecast the revenues and analyze the trends in each of the following sub-markets: Based on Drug Type, the market was studied across Alcohol, Marijuana, Prescription and Over-the-Counter Medications, Synthetic Cannabinoids, and Tobacco/Nicotine and Vaping. Based on Treatment, the market was studied across Counseling and behavioral therapies, Detoxification, Medications, Rehabilitation programs, and Self-help groups. Based on End-user, the market was studied across Hospital and Clinics and Residential treatment centers Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Addiction Disorders Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. Market Dynamics Drivers Increasing Prevalence of Addictive Substances Such as Alcohol, Tobacco, and Drugs Among All Age Groups Government Intervention and Encouragement to Curb Addiction Disorders Rising Number of Approved Medicines and
http://dlvr.it/SgyYW5

Franklin Street Properties Corp. Declares Quarterly Dividend

WAKEFIELD, Mass.--(BUSINESS WIRE)--Franklin Street Properties Corp. (“FSP”, “our” or “we”) (NYSE American: FSP) announced today that its Board of Directors declared a quarterly dividend of $0.01 per share of common stock for the period October 1, 2022 through December 31, 2022, payable on February 16, 2023 to stockholders of record as of January 27, 2023. This press release, along with other news about FSP, is available on the Internet at www.fspreit.com. We routinely post information that may be important to investors in the Investor Relations section of our website. We encourage investors to consult that section of our website regularly for important information about us and, if they are interested in automatically receiving news and information as soon as it is posted, to sign up for E-mail Alerts. About Franklin Street Properties Corp. Franklin Street Properties Corp., based in Wakefield, Massachusetts, is focused on infill and central business district (CBD) office properties in the U.S. Sunbelt and Mountain West, as well as select opportunistic markets. FSP seeks value-oriented investments with an eye towards long-term growth and appreciation, as well as current income. FSP is a Maryland corporation that operates in a manner intended to qualify as a real estate investment trust (REIT) for federal income tax purposes. To learn more about FSP please visit our website at www.fspreit.com.
http://dlvr.it/SgrtPw

Consumer Protection Provides Update on Opening Day of Connecticut Adult-Use Cannabis Market

No issues reported; Initial seed-to-sale data shows robust sales on opening day CONNECTICUT: The Department of Consumer Protection has received the first sales reports from BioTrack, the inventory tracking system used to monitor the movement of cannabis products in the state’s medical and adult-use cannabis markets.  Sales in the adult-use cannabis program began at 10 a.m. Read the full article...
http://dlvr.it/SgkWq6

WSLCB Releases CCRS Updates: Issues Identified – User Action Required

WASHINGTON:The limited issues with the newest version of CCRS have been identified – most can be accommodated by small changes in user submissions. Manifests: Manifest are being processed and a PDF delivered to the submitter as intended. Users can submit the new Manifest.CSV files. The contingency Manifest is still available for use if Manifest PDFs Read the full article...
http://dlvr.it/Sgk4Vn

Governor Lamont Announces Start of Adult-Use Cannabis Sales at Connecticut’s First Group of Licensed Retailers

New Industry Will Bring Jobs, Economic Growth, and Reinvestment in Communities Harmed by Cannabis Prohibition CONNECTICUT: Governor Ned Lamont today announced that first legal retail sales in Connecticut of adult-use cannabis to all adults aged 21 and over began this morning at several retailers that have been licensed to sell the products. The licensed retailers Read the full article...
http://dlvr.it/Sggcbm

Virpax Pharmaceuticals Engages Destum Partners to Direct Strategic Global Partnering Efforts

BERWYN, Pa.--(BUSINESS WIRE)--Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indications, today announced that the Company has engaged Destum Partners, Inc. to serve as the exclusive advisor for the Company's partnering and licensing efforts in strategic global markets. This initial engagement will encompass the Company’s two over-the-counter (OTC) product candidates, Epoladerm™, indicated for osteoarthritis pain, and AnQlar™, an intranasal mucosal viral barrier. Additionally, Destum Partners will work with Virpax on identifying a partner in the animal health market for its Rx product candidate, Probudur™, a long-acting local anesthetic indicated for postoperative pain management. “
http://dlvr.it/Sgg96k

Global Plant-Based Beverages Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Plant-Based Beverages Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The global plant-based beverages market size reached US$ 24.76 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 54.09 Billion by 2027, exhibiting a CAGR of 13.91% during 2021-2027. Companies Mentioned Blue Diamond Growers Inc Califia Farms LLC Danone S.A. Drink Koia Online Kikkoman Corporation Organic Valley Pacific Foods of Oregon LLC (Campbell Soup Company) PureHarvest Ripple Foods SunOpta Inc. The Coca-Cola Company Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor. Plant-based beverages refer to healthy drinks that are manufactured and processed from plant materials, such as grains and seeds, and extracted in water. Rice milk, soymilk, tea and coffee are some of the commonly available plant-based beverages. They are low in calories and rich in protein, calcium, vitamins A and D, and B-complex, and DHA omega-3s or probiotics. Plant-based beverages are commonly consumed as an alternative to dairy products as they consist of a healthy combination of mono- and polyunsaturated fats and have zero concentration of lactose. As a result, plant-based beverages assist in reducing the risk of developing heart diseases, strokes, and diabetes. Increasing health consciousness among masses across the globe is creating a positive outlook for the market. Plant-based beverages provide hydration and serve as a source of various essential nutrients, vitamins, minerals and protein that helps in lowering the risk of cardiovascular diseases (CVDs), improving immunity, and strengthening bone health. In line with this, the widespread consumption of plant-based beverages among the vegan population due to the rising prevalence of lactose intolerance and various kinds of food allergies is favoring the market growth. Apart from this, the launch of plant-based beverages formulated with additional healthy ingredients, such as oat-based options, are providing a considerable boost to the market growth. Additionally, the increasing demand for plant-based supplements in the sports and nutrition industry is positively impacting the market growth. Other factors, including rising expenditure capacities of consumers, the widespread product adoption in cafes and bakeries, significant advancements in processing technologies, and the increasing demand for ready-to-drink (RTD) beverages due to the busy lifestyles and hectic schedules, are anticipated to drive the market further toward growth. Key Market Segmentation: The publisher provides an analysis of the key trends in each sub-segment of the global plant-based beverages market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, product and distribution channel. Breakup by Type: Soy-based Coconut-based Almond-based
http://dlvr.it/SgfF7w

High Tide Opens First Canna Cabana Store In Kamloops, British Columbia

CALGARY, Alberta--(BUSINESS WIRE)--High Tide Inc. (“High Tide” or the “Company”) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets, announced today that its Canna Cabana retail cannabis store located at 1055 Hillside Dr, Kamloops, British Columbia has begun selling recreational cannabis products and consumption accessories for adult use. This brings High Tide’s total number of branded Canna Cabana locations across Canada to 151, including 7 in British Columbia. This new store represents the first Canna Cabana in the city of Kamloops and is a 15-minute walk from Thompson Rivers University, with an on-campus student population of over 13,000 and a scenic 250-acre campus. The store is also at the base of several hiking trails, and it is located in a shopping complex anchored by a major discount grocer and retailer. Finally, this bricks-and-mortar location is a short drive from Aberdeen Mall, a hub of retail activity in Kamloops. “I am pleased to announce the opening of our first Canna Cabana in Kamloops, the 10th largest city in British Columbia. This beautiful city, nestled in the south-central part of the province, is a stop for many athletes each year as Kamloops plays host to hockey, baseball, curling and other tournaments. I hope we can welcome some of these visitors into our store, expanding our reach and brand recognition with Canadians,” said Raj Grover, President and Chief Executive Officer of High Tide. “Anchored by a major discount retail chain, this location is poised to benefit from high levels of traffic coming into this power centre. This location is our seventh Canna Cabana in the province of British Columbia and moves us closer to our goal of reaching eight stores, the current maximum permitted by any entity in the province,” added Mr. Grover. Further to the Company's news release dated December 29, 2022, the Company paid an arm’s length finders’ fee of 136,266 common shares of the Company, in relation to the Company’s successful acquisition of Jimmy’s, which was based on 5% of the aggregate consideration and were issued on the basis of a deemed price of C$2.0365 per share. ABOUT HIGH TIDE High Tide is a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets. The Company is the largest non-franchised cannabis retail chain in Canada, with 151 current locations spanning British Columbia, Alberta, Saskatchewan, Manitoba and Ontario. The Company is also North America’s first cannabis discount club retailer, under the Canna Cabana banner, which is the single-largest cannabis retail brand in Canada, with additional locations under development across the country. High Tide’s portfolio also includes retail kiosks and smart locker technology – Fastendr™. High Tide has been serving consumers for over a decade through its established e-commerce platforms, including Grasscity.com, Smokecartel.com, Dailyhighclub.com, and Dankstop.com and more recently in the hemp-derived CBD space through Nuleafnaturals.com, FABCBD.com, BlessedCBD.co.uk, BlessedCBD.de, and Amazon United Kingdom, as well as its wholesale distribution division under Valiant Distribution, including the licensed
http://dlvr.it/Sgbrw4

Uruguay CBD and Cannabis Regulation Report 2022: Uruguay is on a Path to Becoming of the Main Cannabis-exporting Countries in the World – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Uruguay: CBD and Cannabis Regulation 2022" report has been added to ResearchAndMarkets.com's offering. This report provides a detailed overview of the regulatory framework in place in Uruguay for hemp, cannabis and CBD. Uruguay is on a path to becoming of the main cannabis-exporting countries in the world. The country is planning to boost its recreational cannabis market and attract tourism by allowing non-residents access to both recreational and medical cannabis. Changes are also expected with medical cannabis, with new regulation that could be passed by the end of the year. We could also see changes in CBD regulation with possible allowance for CBD to be used in foods. Key Topics Covered: 1 Executive summary 2 Outlook 3 Hemp and CBD 4 Extracts and synthetics as finished products 5 Finished products containing CBD and extracts 6 Import and export requirements 7 Minor cannabinoids 8 Medical cannabis 9 Recreational cannabis 10 Relevant laws 11 Relevant bodies For more information about this report visit https://www.researchandmarkets.com/r/ckv6l2
http://dlvr.it/SgTKKf

Taiwan CBD and Cannabis Regulation Report 2022: No Changes Appears to be Imminent in the Regulatory Environment – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Taiwan: CBD and Cannabis Regulation 2022" report has been added to ResearchAndMarkets.com's offering. This report provides a detailed overview of the current regulatory framework in place for CBD, hemp and cannabis in Taiwan, covering all policy areas from cultivation and processing to extracts, finished products and import/export. The growing of hemp for any purpose, including the extraction of CBD, is prohibited in Taiwan by the Narcotics Hazard Prevention Act. No change appears to be imminent in the regulatory environment for hemp in Taiwan. Although the public has called on the authorities to legalise medical cannabis, it is unlikely to happen in the near future. Key Topics Covered: 1 Executive summary 2 Outlook 3 Hemp plant 4 Extracts as finished products 5 Finished products containing CBD and extracts 6 Import and export 7 Medical cannabis 8 Recreational cannabis 9 Relevant laws 10 Relevant bodies For more information about this report visit https://www.researchandmarkets.com/r/wgl3zg About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
http://dlvr.it/SgR38s

WSLCB Issues Important Update for Social Equity Cannabis Retail License Applicants: New Instructional Courses and Upcoming Webinar Series Jan. 24 and Jan. 28, 2023

WASHINGTON: The Liquor and Cannabis Board (LCB) will soon be opening the application window for a limited number of retail cannabis licenses that have been reserved for social equity purposes. The LCB has partnered with MakeGreenGo! to provide technical assistance and business education for potential social equity applicants. MakeGreenGo! is a company with experience providing Read the full article...
http://dlvr.it/SgNF4t

Virpax Pharmaceuticals Engages Dr. Kenneth W. Sommerville and Dr. Lawrence Fried to Assist in Development of NobrXiol™ (formerly VRP324)

BERWYN, Pa.--(BUSINESS WIRE)--Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indications, today announced that it has engaged two leading physicians experienced in childhood epilepsy, Dr. Kenneth W. Sommerville and Dr. Lawrence Fried, to support the overall development plan for NobrXiol. Their involvement with this program is expected to include advising on trial design, regulatory pathway development and patient recruitment. Additionally, it is anticipated that they will support Virpax with patient advocacy groups and grant applications. NobrXiol is the Company’s product candidate for the delivery of cannabidiol in the management of epilepsy in children and adults that utilizes the Nanomerics Molecular Envelope Technology (MET) as its delivery system to cross the blood brain barrier, propelling the cannabidiol nanoparticles through the nose to the brain via the olfactory nerve. Dr. Kenneth W. Sommerville is a board-certified neurologist with over 30 years of experience working with major multinational pharmaceutical companies enabling approvals for numerous drugs with both the FDA and the EMEA. He is a recognized authority in drug development with an expertise in anti-epileptic drugs, pain, and abuse-deterrent opioids. Dr. Sommerville was in charge of Phases II and III of the U.S. epilepsy trials for cannabidiol. The lead cannabinoid, CBD (Epidiolex®), received FDA approval in June of 2018. Dr. Lawrence Fried is an experienced clinical leader in epilepsy and neurology and a practicing epileptologist. He currently serves as an Attending Physician in the Pediatric Regional Epilepsy Program at the Children’s Hospital of Philadelphia, as well as an Assistant Professor of Clinical Neurology at the University of Pennsylvania and is a Corporate Advisory Committee member of the American Epilepsy Society. Following medical school, he completed five years in residency positions in pediatrics and pediatric neurology, followed by a fellowship in epilepsy and pediatric neurology and has published extensively in those fields. “
http://dlvr.it/SgNDwy

New Jersey Recreational Cannabis Sales Jump to +$100 Million in 2022 Third Quarter

NEW JERSEY: Sales receipts on recreational cannabis in New Jersey for July 2022 to September 2022 totaled $116,572,533. With medicinal cannabis sales included, the total goes up to $177,710,764. There are now 20 dispensaries in New Jersey selling recreational cannabis; another 10 sell medicinal cannabis to registered patients only. “New Jersey is only seeing the Read the full article...
http://dlvr.it/SgKkyl

United States New Franchise Concept Report (NCR) 2023 Featuring up to 300 Contact Leads for Brands Discussed – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "United States New Franchise Concept Report (NCR)" newsletter has been added to ResearchAndMarkets.com's offering. The United States New Franchise Concept Report is an annual subscription to quarterly reports that provides valuable insight into new franchise concepts added to the analyst's database. It is an invaluable sales and marketing tool for any company looking to target the franchise market long-term. The United States New Franchise Concept Report enables subscribers to: Build deeper long term relationships by securing long term relationships with brands in their early stages of growth Gain a competitive advantage, reach new up and coming concepts before other suppliers do Maximize your salespeople's time by enabling them to focus only on the best leads with the most potential to scale Enable your market messaging to resonate Finding new franchises with true potential can be challenging - new businesses are opening every day, but long-term success rates for entrepreneurs are low. So which businesses present valuable, long-term opportunities for suppliers? Attending events to generate leads is often costly and less advantageous than expected; moreover, constantly searching to discover investment opportunities as they arise can involve hours of effort with little to no avail. The analyst has access to franchise information before any other firm of its kind and they compile their new concepts list on a quarterly basis to keep interested investors and suppliers updated, thus expediting the process of finding promising new franchises. Franchises enter this report when the analyst "discovers" them and codes them with their Unique Numbering System (FRUNS) for the first time. The overwhelming majority have been franchising for 3 years or less. The report will help you find new brands to market to more quickly. The analyst has a first-look advantage with emerging franchise brands through their FDD filings and our ongoing discovery process, which includes site visits and executive contacts from these new businesses. The analyst is the only company that tracks all of the franchise brands in the United States while verifying their viability in the marketplace. The United States New Franchise Concepts Report subscription delivers the following: 4 quarterly reports that provide insights that can make a difference to your sales and marketing efforts 200-300 contact leads for the brands discussed in the issue, including executive contacts An executive contact list of the management team at each franchise brand, including titles, job codes, HQ addresses, HQ phones, and websites. Utilize the report to create sales preparatory information that qualifies them as leads and initiate intelligent communication with the brand Companies Mentioned 3 Natives Cafe 55Fitness A.C.E. Janitorial All MedSearch Barry's Cheesesteaks and More BeLocal Bengal Bay Grill Big Block Realty Burger Boss Grassfed Natural Goodness Buzzed Bull Creamery CamiCakes Cupcakes
http://dlvr.it/SgKHm0

The Worldwide Hemp Clothing Industry is Expected to Reach $10.1 Billion by 2028: Low Cost of Hemp Fabric Drives Growth – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Hemp Clothing Market Size, Share & Industry Trends Analysis Report By End User (Women, Men and Kids), By Type (Dress, Shirts, Pants, Coats & Jackets, Activewear, T-shirts), By Distribution Channel, By Regional Outlook and Forecast, 2022 - 2028" report has been added to ResearchAndMarkets.com's offering. The Global Hemp Clothing Market size is expected to reach $10.1 billion by 2028, rising at a market growth of 26.0% CAGR during the forecast period. Hemp fiber is produced from the Cannabis sativa plant, which is better known for producing marijuana or hashish. Nevertheless, hemp only has 1% THC, contrary to marijuana's 20% THC content, which is what causes consumers to feel high when they smoke it. Amazing characteristics of this fiber include exceptional dyeability, UV light blocking, mildew resistance, and inherent antibacterial properties. It effectively transfers heat as well. Some of the industries that use it include paper, building, biodegradable plastic, chemical cleanups, healthy food, and fuel. Hemp fiber is used to reinforce door panels by automakers like BMW in order to improve safety norms. Compared to other fabrics, hemp cloth uses less water, pesticides, chemical fertilizers, and herbicides. It is more successful at extracting carbon dioxide from the environment than many other crops, which results in a smaller carbon footprint. Hemp can absorb 10 to 15 tonnes of CO2 per acre throughout the growing season, which is equivalent to one person's usual annual CO2 emission. On the list of sustainable textiles and fibers, hemp is listed alongside jute, flax (linen), organic cotton, and bamboo. Hemp fiber from the stem and seed can be used to make insulation and animal bedding, respectively. The earth benefits from hemp as well. The production of maize from a field will be higher if hemp was initially grown there. It's also a good idea to plant wheat and barley once the hemp crop has been harvested. Due to the potential benefits to the environment, several producers are working to have hemp and cannabis grown according to organic standards. It has been widely publicized how much the fashion business contributes to the pollution and destruction of the rivers, oceans, and atmosphere. Every second, an estimated truckload of discarded clothing is burned or dumped. Although there are many residents who are concerned, the current sustainable fashion solutions are expensive and time-consuming. As consumer attitudes toward the environment & ecology have evolved, there is a greater need for eco-friendly clothes. Market Growth Factors Low Cost Of Hemp Fabric The fact that hemp is a rapidly renewable resource and doesn't require the use of artificial fertilizers or pesticides has a positive impact on the environment. Hemp can be renewed two to three times per year and generates more fiber per acre than trees. Additionally, nothing is wasted during the production of hemp because the stalks are used to generate fiber and the seeds are used to make dietary supplements and oil. Industrial hemp plants are better
http://dlvr.it/SgJr9y